Home Back Issues February 2014 Happy chemicals

Happy chemicals

| Print |  Email
Articles - February 2014
Tuesday, January 21, 2014

0214 NEXTBY LINDA BAKER

Although millions of people take anti-depressants, scientists know astonishingly little about how these therapies actually work. “It was kind of hit or miss; the measure was whether the person got better or not,” says Eric Gouaux, a senior scientist at OHSU’s Vollum Institute. Now Gouaux and his lab are shedding new light on a previously cloudy process: Their research focuses on the dopamine transporter, a protein that helps regulate levels of dopamine, a neurotransmitter. Abnormal levels of dopamine are present in a variety of disorders, including depression. So what is Gouaux’s scientific breakthrough? “For the first time, we are able to visualize the molecular details of what the antidepressant does when it binds to a biologically active site,” he says. In layman’s terms: “We can finally see the lock in which keys have been placed.” The key to success was solving the 3-D crystal structure of the dopamine transporter, a notoriously difficult task that has stymied scientists for decades. The next step is to gain insight into better therapies, as well as to visualize the impact of drugs such as methamphetamine and cocaine, which exert much of their biological effect by inhibiting the dopamine transporter. In the meantime, Gouaux, who has labored four years on the project, is pretty happy with his lab’s pioneering discovery. “It’s been a pilgrimage,” he says.

 

More Articles

Knight Vision

October 2014
Thursday, September 25, 2014
BY VIVIAN MCINERNY

Travis Knight wants to release a movie a year. Can he pull it off?


Read more...

What I'm Reading

October 2014
Thursday, September 25, 2014

Nick Herinckx, CEO of Obility, and Jake Weatherly, CEO of SheerID, share what they've been reading.


Read more...

Innovation: a critique

News
Wednesday, October 08, 2014
1008 innovation thumbBY LINDA BAKER | OB EDITOR

A Design Week panel discussion raises questions about how innovative we really are.


Read more...

Healthcare pullback

News
Thursday, November 20, 2014
112014-boehnercare-thumbBY JASON NORRIS | OB CONTRIBUTOR

Each month for Oregon Business, we assess factors that are shaping current capital market activity—and what they mean to investors. Here we take a look at two major developments regarding possible rollbacks of the Affordable Care Act (ACA).


Read more...

Downtime

October 2014
Thursday, September 25, 2014
BY JESSICA RIDGWAY

I'm not very interesting,” says a modest Ray Di Carlo, CEO and executive producer of Bent Image Labs, an animation and visual effects studio.


Read more...

Gone Girl

News
Monday, September 29, 2014
roundup-logo-thumb-14BY LINDA BAKER | OB EDITOR

Wehby disappears, Kitzhaber fails to disclose and Seattle gets bike share before Portland.


Read more...

Grape Expectations

October 2014
Thursday, September 25, 2014
BY HANNAH WALLACE

Well-financed outsiders from France and California are buying up vineyards and wineries in the Willamette Valley.


Read more...
Oregon Business magazinetitle-sponsored-links-02
SPONSORED LINKS